Single-Cell Multi-Omics Defines H3K27Me3 Remodelling In Intervertebral Disc Degeneration With Implications For Regenerative Intervention
Chronic lower back pain, a widespread issue, often stems from the degeneration of intervertebral discs—the cushions between our spinal bones. This process involves a shift in the cells within these discs. Early in life, the disc’s core contains special cells called notochordal cells, which have strong regenerative abilities. However, as we age and discs degenerate, these are replaced by less effective nucleus pulposus cells.
To understand this complex process at a fundamental level, researchers employed advanced techniques known as single-cell multi-omics. This approach allowed them to examine individual cells and gather comprehensive data on their gene activity (transcriptomics) and how their DNA is packaged and regulated (chromatin states). By looking at these details across different stages of disc health, from juvenile to degenerate adult, they uncovered crucial changes.
One key finding involved a specific “epigenetic mark” called H3K27me3. This mark acts like a switch on our DNA, typically turning genes off. The study showed that in degenerating discs, there was an increase in H3K27me3 on genes vital for disc development and health, such as Brachyury. This effectively silences these important genes, contributing to the disc’s decline.
Crucially, the research demonstrated that by removing these repressive epigenetic marks and utilizing gene-editing tools, it was possible to boost the expression of genes like Brachyury in human nucleus pulposus cells from degenerated discs. This suggests a promising path forward: by understanding and manipulating these cellular cues, we might be able to help degenerated disc cells regain a healthier, more regenerative state, offering new hope for treating chronic back pain.
Source: link to paper